Mix-and-match trial finds additional dose of COVID-19 vaccine safe and immunogenic
All combinations of primary and booster vaccine resulted in increased neutralising antibody levels (ranging from 4.2- to 76-fold…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Israel broadens eligibility for fourth shot of COVID vaccine
Earlier this month, Israel began offering the fourth jab to people over 60, on the condition that at least five months have passed…
Lonza’s full-year core EBITDA up 20.7 per cent on vaccine demand
Full-year core earnings before interest, tax, depreciation and amortisation (EBITDA) rose to 1.67 billion Swiss francs ($1.82…
Each dose of Covishield and Covaxin likely to be capped at Rs 275 after getting regular market…
National Pharmaceutical Pricing Authority (NPPA) has been directed to start working towards capping the price to make the vaccines…
Sun Pharma launches Cequa, maiden dry eye treatment with nanomicellar technology in Canada
Cequa’s nanomicellar (NCELL) technology improves the bioavailability and physicochemical stability of cyclosporine to increase…
JB Chemicals and Pharmaceuticals to acquire brands from Sanzyme
The acquisition for approximately Rs 628 crores will mark the company's entry into the probiotics, therapeutic nutraceuticals and…
Torrent Pharma December quarter profit slips 16 per cent to Rs 249 crores
The drugmaker had posted a net profit of Rs 297 crores in the October-December period of the 2020-21 fiscal
‘Nocebo effect’ behind two-thirds of COVID vax side effects: Study
The "nocebo effect" occurs when a person experiences unpleasant side effects after taking a treatment with no pharmacological…
US limits use of Regeneron and Eli Lilly COVID-19 antibody treatments amid Omicron spread
The Food and Drug Administration (FDA) said the treatments are currently not cleared for use in any US states or territories, but…
Omicron may not evade all monoclonal antibodies, lab study suggests
Several past studies have shown that such antibodies are unsuccessful in neutralising Omicron